Rosetta Genomics Ltd. (ROSGQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Sep 4, 2025, 8:00 PM EDT
Rosetta Genomics Market Cap
Rosetta Genomics has a market cap or net worth of $593.00 as of September 5, 2025. Its market cap has decreased by -99.93% in one year.
Market Cap
593.00
Enterprise Value
n/a
Revenue
2.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 27, 2007, Rosetta Genomics's market cap has decreased from 82.42M to 593.00, a decrease of -100.00%. That is a compound annual growth rate of -47.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2025 | 593.00 | 9,783.33% |
| Dec 27, 2024 | 6.00 | -98.99% |
| Dec 29, 2022 | 593.00 | - |
| Dec 31, 2021 | 593.00 | -99.50% |
| Dec 31, 2020 | 118.60K | 566.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 840.66M |
| Elite Pharmaceuticals | 760.21M |
| Tian'an Technology Group | 673.67M |
| Glass House Brands | 576.95M |
| CytoDyn | 401.20M |
| Northwest Biotherapeutics | 387.41M |
| American Oncology Network | 352.23M |